Sales Division: Sales Leader in South area• Strategic management from M1 to M4 market with tailored tactics • Effective KOL management in key hospitals w excellent clinical & economic values• Based on AI deep learning, hold regional symposium at reference sites for potential users.• Financial solution to a potential accounts with optimized suggestion• One team spirit with team members, internal / external stakeholders• Intensive training for improving each territory managers for academic approach• Develop un-tapped market by segmenting customers & finding unmet demand

• Responsibility of whole Interventional cardiology (revenue : 60 B KRW)• Achieving 102% vs. sales target in 2018• Achieving 131% vs. sales target in 2017• M/S 75% in IVUS (intravascular ultrasound) Korea market (vs. Global: 15%)• 2017 Global Award  Global President Marketing Excellence Award① No.1 growth rate(% 31 growth rate vs. PY2016 in Asia pacific)② Successful new product release (IVUS, Sentai wire,CTO device)③ Well –organized Global symposium (TCTAP, Expert Exchange,G4 program)  AMEA Marketing Excellence Award AMEA PTW Achievement Award• Clinical research with top10 hosp. Cardio intervention clinical study with SNUH, SMC, AMC, BNUH and etc.• NPI Launching to main market as new growth engine POLARIS Imaging system with FFR procedure SENTAI Guidewire launching CTO Device with Bridge point (Stingray + CrossBoss)• Global Congress implementation : TCTAP, ENCORE and KSIC Launching program Innovation seminar Customer VOC program• Seamless collaboration between KOREA & ASEAN  G4 MKT program IVUS (intravascular ultrasound) symposium IAS, ROVUS Education program China CTO (Chronic Total Occlusion) proctorship program

• Responsibility of whole CT business (revenue : 20 billion KRW)• Achieving 130% vs. sales target in 2015• M/S 25% ( vs. Global M/S : 10%) in 2015• Reporting to CT/MRI marketing director• Implement strategic market development program Setting price map based on market situation Developing dedicated package solution for large scale project & low-end market• Successful launching of super premium product (IQon & iCT elite)• Leadership forum of IQon Spectral CT for cardiac • SENSE symposium for PHILIPS local users

• Set up qualified channel partners for expanding low-end market Managing 4 exclusive distributors and 15 sub-dealers in Korea Ultrasound biz. : WONIK corporation (KOSDAQ) Imaging system business: local-based partner PCMS (Patient care monitoring service) biz. : Local-based partner.• Systemic funnel management & create strategic solution • Activate IB (Install-based) biz. with finance solution

• Responsibility of whole refractive surgery in Ophthalmology (revenue : 20 billion KRW)• Achieving 105% vs. sales target in 2011• Achieving 107% vs. sales target in 2012• Market Share: 60% in refractive biz.• Reporting to General manger• Tailed solution for EQ + disposable to lead refractive market for top 10 accounts • Through regular sales meeting with exclusive distributor for expanding this market• Marketing initiative & program Abbott Medical Optics University(AMO U) symposium  iLASIK Rebounding Project with key distributor in 2011 iFS Offline marketing on BUS advertisement  iDESIGN launch(diagnosis EQ) in 2013

• Achieving 180% vs. sales target in 2009 and 115% vs. sales target in 2008 • Organize direct & indirect system since partnership with Dong-A pharm • Re-arranging local qualified dealers for maximizing biz. synergy effect• New product launching & listing in key hosp. ① IM nailing ② Cannulated screw③ Gamma nail• Implementing in-depth product training for channel partners.

• Achieving 112% vs. Prozac sales target in 2004• Achieving 109% vs. sales target in 2004• Launch of new product in Large Hosp. and 15 clinics Zyprexa IM, Zydis, Prozac dis & weekly in Aju Univ. Hosp &b CMC Vincent Hosp.• Developing key strategy for marketing member